secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-10-13T21:00:46+00:00
Accession:  0001493152-26-046863
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Intelligent Bio Solutions adopts Second Amended and Restated Bylaws; majority-vote standard clarified
--------------------------------------------------------------------------------

- Board adopted the Second Amended and Restated Bylaws effective October 12, 2026, revising Section 2.6 on stockholder voting.
- Non-director matters now decided by affirmative vote of a majority in voting power of votes cast; abstentions and broker non-votes are excluded and have no effect.
- An investor presentation was made available October 13, 2026 via the Investors section of www.ibs.inc (furnished as Exhibit 99.1).
- Exhibit 99.1 text was not appended to the filing, so no presentation figures, guidance or business updates can be reported.
- Signed by CFO Spiro Sakiris; common stock (INBS) trades on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226046863/0001493152-26-046863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226046863/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-046863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer